Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Kaleido Biosciences (KLDO)

Kaleido Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KLDO
DateTimeSourceHeadlineSymbolCompany
06/05/202213:16Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:KLDOKaleido Biosciences Inc
02/05/202211:20Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KLDOKaleido Biosciences Inc
27/04/202210:03TipRanksAnalysts Offer Insights on Healthcare Companies: and Kaleido Biosciences (KLDO)NASDAQ:KLDOKaleido Biosciences Inc
25/04/202221:43Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KLDOKaleido Biosciences Inc
25/04/202221:41Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KLDOKaleido Biosciences Inc
18/04/202214:25Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:KLDOKaleido Biosciences Inc
08/04/202214:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KLDOKaleido Biosciences Inc
04/04/202212:45TipRanksKaleido Biosciences (KLDO) was Downgraded to a Hold Rating at Chardan CapitalNASDAQ:KLDOKaleido Biosciences Inc
16/03/202212:30GlobeNewswire Inc.Radius Health Announces Leadership AppointmentsNASDAQ:KLDOKaleido Biosciences Inc
09/03/202221:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KLDOKaleido Biosciences Inc
02/03/202221:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
02/03/202221:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
28/02/202214:00PR Newswire (US)Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory AffairsNASDAQ:KLDOKaleido Biosciences Inc
15/02/202215:05PR Newswire (US)INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANTNASDAQ:KLDOKaleido Biosciences Inc
09/02/202214:25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KLDOKaleido Biosciences Inc
28/01/202221:44Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KLDOKaleido Biosciences Inc
21/01/202216:04GlobeNewswire Inc.Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn’s and Colitis CongressNASDAQ:KLDOKaleido Biosciences Inc
18/01/202222:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
18/01/202222:13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
18/01/202222:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
18/01/202222:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
16/12/202122:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
16/12/202122:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:KLDOKaleido Biosciences Inc
06/12/202112:30GlobeNewswire Inc.Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic ConditionsNASDAQ:KLDOKaleido Biosciences Inc
15/11/202112:30GlobeNewswire Inc.Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ConferenceNASDAQ:KLDOKaleido Biosciences Inc
10/11/202112:30GlobeNewswire Inc.Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical OfficerNASDAQ:KLDOKaleido Biosciences Inc
01/11/202111:30GlobeNewswire Inc.Kaleido Biosciences Reports Third Quarter 2021 Financial ResultsNASDAQ:KLDOKaleido Biosciences Inc
13/10/202115:11PR Newswire (US)Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate ChangeNASDAQ:KLDOKaleido Biosciences Inc
12/10/202112:30GlobeNewswire Inc.Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics SummitNASDAQ:KLDOKaleido Biosciences Inc
05/10/202112:00GlobeNewswire Inc.Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement of KB295 to a Phase 2 Clinical Study in Mild-to-Moderate Ulcerative ColitisNASDAQ:KLDOKaleido Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:KLDO